RAPT THERAPEUTICS
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In its first four years since inception, RAPT has discov... ered and advanced two unique drug candidates, each targeting C-C motif chemokine receptor 4. The company’s lead oncology drug candidate, FLX475, reached the clinic in just two and a half years with its lead inflammation drug candidate, RPT193, also in the clinic. The company is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1, that are in the discovery stage of development.
RAPT THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2015-03-04
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.rapt.com
Total Employee:
101+
Status:
Active
Contact:
+116504899000
Total Funding:
369.7 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Microsoft GoDaddy SSL Smart App Banner
Similar Organizations
Actym Therapeutics, Inc.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Cyclica
Cyclica is the partner of choice for data-driven drug discovery.
Effector Therapeutics
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
GlycoBioChem
GlycoBioChem is focused on discovery and development of novel small-molecules for the purposes of research and treatment of human diseases.
Insitro
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
MiNDERA Corporation
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
QureBio
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.
Rgenta Therapeutics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
ShouTi
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Westlake Therapeutics
The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Board_member
2015-04-01
Board_member
2015-04-01
Board_member
2016-12-01
Board_member
2015-04-01
Board_member
Current Employees Featured
Brian Wong Founder & CEO @ Rapt Therapeutics
Founder & CEO
2015-08-01
William Ho Chief Medical Officer @ Rapt Therapeutics
Chief Medical Officer
2015-05-01
Dave Wustrow VP Discovery and Preclinical Development @ Rapt Therapeutics
VP Discovery and Preclinical Development
Paul Kassner Vice President of Quantitative and Computational Biology @ Rapt Therapeutics
Vice President of Quantitative and Computational Biology
Kristina Green Senior Director, Quantitative Biology @ Rapt Therapeutics
Senior Director, Quantitative Biology
2021-05-01
Rodney Young Chief Financial Officer @ Rapt Therapeutics
Chief Financial Officer
2019-12-01
William Ho Chief Medical Officer @ Rapt Therapeutics
Chief Medical Officer
2015-05-01
Dirk G. Brockstedt Chief Scientific Officer @ Rapt Therapeutics
Chief Scientific Officer
2019-06-01
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Rapt Therapeutics
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Rapt Therapeutics
Topspin Partners
Topspin Partners investment in Series C - Rapt Therapeutics
The Column Group
The Column Group investment in Series C - Rapt Therapeutics
Regents of the University of California
Regents of the University of California investment in Series C - Rapt Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - Rapt Therapeutics
Topspin Partners
Topspin Partners investment in Series C - Rapt Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - Rapt Therapeutics
Celgene
Celgene investment in Series C - Rapt Therapeutics
GV
GV investment in Series C - Rapt Therapeutics
Official Site Inspections
http://www.rapt.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rapt Therapeutics"
Rapt - Crunchbase Company Profile & Funding
Rapt, Inc. offers media monetization solutions, and technology and strategic advisory services to media companies. The company also provides advertising yield management solutions. Its …See details»
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California. Corporate Governance RAPT Therapeutics, Inc.’s ISS Governance QualityScore as …See details»
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
May 4, 2022 “We are pleased to attract such high caliber talent as we continue to grow our organization and make advances in our inflammatory disease and cancer programs. Gwen is …See details»
Corporate Governance - RAPT Therapeutics, Inc.
The Board of Directors of RAPT Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
THE RAPT FOUNDATION – Making a Difference One …
The RAPT Foundation is a professional Foundation of individuals dedicated in assisting with the medical, developmental, and educational well being of children in indigent communities. As an IRS fully recognized 501 C 3 organization, the …See details»
Investor Relations | RAPT Therapeutics, Inc.
Mar 7, 2025 RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …See details»
RAPT - Organizations - Acronym Finder
What does RAPT stand for? Your abbreviation search returned 7 meanings. showing only Organizations definitions . Link/Page Citation Category Filters; All definitions (7) Information …See details»
RAPT Therapeutics, Inc. (RAPT): history, ownership, mission, how it ...
RAPT Therapeutics's Transformative Moments The Strategic Rebranding. Changing the name from FLX Bio to RAPT Therapeutics in 2018 wasn't just cosmetic. It represented a sharpened …See details»
RAPT Therapeutics - Overview, News & Similar companies
Jan 1, 2020 RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results SOUTH SAN FRANCISCO, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- RAPT …See details»
RAPT™ Creative - Integrated Agency
RAPT™ is an Independent and Proudly South African Agency. We are a full service and integrated Through-The-Line Agency. We are invested in our clients businesses and believe in great partnerships to constantly challenge and shift …See details»
Rapt Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Apr 1, 2025 SOUTH SAN FRANCISCO, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”) is a clinical-stage immunology …See details»
RAPT Therapeutics (RAPT) Company Profile & Description - Stock …
Oct 31, 2019 RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and …See details»
Rapt Therapeutics - Crunchbase Company Profile & Funding
Organization. Rapt Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... RAPT Therapeutics is a clinical …See details»
Rapt - VentureRadar
RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and …See details»
A Brief History of Rapt Therapeutics – CanvasBusinessModel.com
Dec 19, 2024 A Brief History of Rapt Therapeutics: Founded in 2015, Rapt Therapeutics is a biopharmaceutical company dedicated to the development of innovative therapies for cancer …See details»
RAPT Commerce - RAPT™ Creative - Integrated Agency
RAPT Commerce is an end to end main market engagement solution using robust data to drive measurable sales uplift. We’re not talking about fluffy “awareness” numbers. We’re talking …See details»
RAPT - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 13, 2025 RAPT has raised a total funding of $199M over 7 rounds. Its first funding round was on 2015. Its latest funding round was a Post IPO round on Dec 23, 2024 for $150M. 10 …See details»
What does RAPT mean? - Definitions.net
What does RAPT mean? Information and translations of RAPT in the most comprehensive dictionary definitions resource on the web. Login . The STANDS4 Network. ... Its advisory …See details»
Rapt | Home
Rapt gives us light touch customer insights early on in the process. Our clients don’t tend to like a lot of discovery research. It feels like it's slowing the process down. Now we can get those light …See details»
Inside the Battle Over OpenAI’s Corporate Restructuring
4 days ago Aguilar’s new organization, LatinoProsperity, focuses on intergenerational wealth building, and he believed cutting-edge AI chatbots such as ChatGPT would become an …See details»